On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


SRAX Inc. (NASDAQ: SRAX) CEO to Host Q3 2019 Financial Results Conference Call

  • SRAX, a digital marketing and consumer data management technology company, has multiple recurring revenue streams through various platforms
  • SRAX’s CEO Christopher Miglino to be joined by key members of SRAX leadership
  • Operational and financial summary call to be webcast live, accessible at company’s website

Digital marketing and consumer data management technology company SRAX Inc.’s (NASDAQ: SRAX) Founder and CEO Christopher Miglino will host the company’s conference call on November 13 at 1:30 p.m. (PST). The call will detail the company’s Q3 2019 operational and financial summary. Joining Miglino on the call will be COO Kristoffer Nelson; CFO Mike Malone; Vice President of SRAX Shopper George Stella; and Vice President of Research Sales Rick McCrady (http://ibn.fm/1fu59).

SRAX is a digital marketing and consumer data management technology company. Through development of its BIGtoken platform, SRAX offers a secure and transparent environment for consumers to own and earn from their data (http://ibn.fm/6HVPF). Developed by SRAX, BIGtoken can be downloaded from both the App Store and Google Play. This platform boasts over 16 million BIGtoken registered users worldwide and provides consumers with a safe and transparent environment for monetization of their data (http://ibn.fm/2KrZT).

Through BIGtoken, SRAX has created a symbiotic relationship between big brands desiring to know their consumers better and the consumers themselves who want to remain in control of their data at ever-increasing rates. In exchange for giving brands access to their data by answering surveys, checking into locations, referring friends, and more, BIGtoken users are rewarded with points, which they can then redeem for cash and gift cards or make charitable donations. SRAX’s technology then unlocks data to reveal the core consumers of brands across marketing channels. As one of the first companies to offer consumers a significant piece of the data pie, SRAX is building the largest and most valuable opted-in data set in the world.

Additionally, while major social media giants like Facebook are backpedaling over mismanagement of users’ privacy, SRAX‘s platform takes care of the consent issue early on in the process. SRAX asks users for permission to share data when they initially sign up for the BIGtoken platform. The company is ahead of the competition in California, where a new privacy law compliance bill designed to protect consumers’ privacy goes into effect January 1, 2020. A report from CNBC noted that the legislation may cause firms to pay in aggregate up to $55 million in initial compliance costs, according to an assessment prepared by an independent research firm for the state attorney general’s office in California (http://ibn.fm/MeWdH).

SRAX’s machine learning technology analyzes marketing data, and its BIGtoken platform enables consumers to own, manage, and sell access to their digital identity and data. This provides SRAX with valuable proprietary data and multiple revenue streams (http://ibn.fm/OEPQu).

To register for the conference call, interested parties can visit http://ibn.fm/tRWDb. The call can be heard live at (877) 451-6152 if calling from the U.S. or Canada. For international participation, listeners should dial (201) 389-0879; the conference ID is 13695604. The call will also be available for at least 90 days on the company’s website.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at  http://ibn.fm/SRAX

Last Tweets

Follow us: @Buy_Stocks_Now

From Our Blog

Predictive Oncology Inc. (NASDAQ: POAI) Key Player in AI Implementation in Ovarian Cancer Detection

December 12, 2019

POAI subsidiary sequencing ovarian cancers as part of CancerQuest 2020 project, building largest ovarian multi-omic database in the world Company’s work designed to speed development of new drugs, provide therapeutic choices Helomics recently signed collaborative agreement with UPMC-Magee to establish data- and artificial-intelligence-driven approach to treating ovarian cancer The power of artificial intelligence (AI) to […]

Rotate your device 90° to view site.